• The U.S. National Stage patent application is part of the company’s strategic initiative to secure its intellectual property on a global scale
• EAWD is not just aiming to become integral to this expanding industry, but also to reassure stakeholders of its environmental responsibility and commitment to sustainability, tapping into the world’s emerging markets
• The patent revolutionizes water resource management by harnessing renewable energy to extract water directly from atmospheric humidity
• The company aims to provide sustainable value to each project while generating revenue by selling its systems and licensing its technologies, along with associated engineering and project management services

Energy and Water Development (OTCQB: EAWD), a green-tech engineering solutions company focused on delivering water and energy to extreme environments, such as water sourcing independent from groundwater that doesn’t require energy from the grid, recently announced the filing of its U.S. National Stage application under 35 USC 371, application number 18/688,661. This application is part of the company’s strategic initiative to secure its intellectual property on a global scale. The application builds on the PCT/EP2021/074299 international application and aligns with filings in key markets, including Canada, Mexico, Brazil, and Colombia (https://ibn.fm/SY8QS).

EAWD, a company deeply committed to the water and energy sectors, prioritizes three key areas: generation, supply, and maintenance. The green tech industry is dynamic, with long-term demand growth driven by increasing water scarcity and energy requirements worldwide. By crafting sustainable solutions to these challenges, EAWD is not just aiming to become integral to this expanding industry, but also to reassure stakeholders of its environmental responsibility and commitment to sustainability, tapping into emerging markets.

The patent describes a groundbreaking technology: the Self-Sufficient Energy Supplied System for Generating Atmospheric Water which revolutionizes water resource management by harnessing renewable energy to efficiently extract water from atmospheric humidity. This innovative system offers a sustainable solution to traditional water sources, particularly vital for regions facing water scarcity and grid challenges.

MSc Irma Velazquez, CEO of EAWD, emphasized the importance of the U.S. filing, saying that the application under 35 USC 371 marks a significant milestone in the company’s commitment to protecting its innovative technology and enhancing its operational footprint globally. “This system is set to revolutionize the way we access clean water, particularly in water-stressed areas, aligning perfectly with our mission of sustainability and technological advancement.”

The global green technology and sustainability market was valued at $10.32 billion in 2020, and is projected to reach $74.64 billion by 2030, growing at a CAGR of 21.9% during the forecast period. The market is expected to grow due to the surge in environmental awareness and increased global warming concerns among organizations and individuals. There has also been a rise in favorable government and private initiatives to tackle climate change and air pollution, providing more opportunities in the market (https://ibn.fm/PBV0U).

EAWD’s strategy is not just about its own success, but also about aiding businesses by ensuring efficient, profitable, and sustainable water and energy supply and generation. This approach enables clients to concentrate on their core operations while embracing sustainability. Through cutting-edge technology provided by EAWD and its partners, clients can optimize their operations while meeting industry water and energy usage regulations, thereby feeling the value and relevance of EAWD to their operations.

EAWD’s business objectives revolve around self-sufficient energy-supplied water generation and green energy production in response to global demand. This involves establishing a green tech platform to commercialize its technologies and offer engineering and technical consultancy services for sustainable solutions.

By filing this patent application to protect its intellectual property, EAWD asserts its leading role in the water solutions industry, bringing fresh prospects for global sustainable development. The company aims to provide sustainable value to each project while generating revenue by selling its systems, licensing its technologies, and offering critical engineering and project management services.

For more information, visit the company’s website at www.Energy-Water.com.

NOTE TO INVESTORS: The latest news and updates relating to EAWD are available in the company’s newsroom at http://ibn.fm/EAWD

Traders, cannabis stakeholders, license holders, physicians, patients, regulatory authorities, entrepreneurs, capital investors, public officials, and enthusiasts, are invited to attend the CannaCon West Albuquerque at the Albuquerque Convention Center on May 17-18, 2024. The event focuses on bringing together all participants in the cannabis industry for two days of intense exploration, interaction, learning, and collaboration.

As Albuquerque is witnessing an evolving cannabis industry, this event provides a phenomenal platform for cannabis veterans and newcomers to build a solid new industry. The CannaCon West Albuquerque is engaged in boosting the West’s cannabis industry. The Albuquerque network consists of like-minded cannabis businesses that stay connected and support each other, paving the way for growth and higher returns.

Influential industry leaders and decision-makers will talk about the latest issues and regulations, trends, innovations, and strategies. They will also answer queries from attendees during discussions and interactive sessions. The CannaCon expo offers a global networking frontier where eminent canna traders and investors visit to discover new and fresh talent and ideas. This event opens up avenues for trade and opportunities for all segments of cannabis industries in the region.

CannaCon is a one-stop shop offering a gamut of services to attendees ranging from retail displays, cultivation supplies, showcasing industry innovations, world-class genetics, business and legal advice, science and technology, finance, marketing, and so on. New and seasoned entrepreneurs and industry leaders will showcase their offerings to ensure visibility among industry experts and professionals.

Attendees can meet and connect with decision-makers, veterans, and investors and grow their network at CannaCon in a fun and conducive environment.

Bookings for exhibitors and speaker sessions are available.

To learn more, please visit https://ibn.fm/Y5FyZ

• The United Nations continues to institute multi-national government policies for transitioning from carbon-based fuels to renewable energy systems in an attempt to address harmful changes to the planet’s climate
• The president of last year’s U.N.-sponsored climate change conference is calling on the most economically powerful nations to help triple the global renewable energy capacity by 2030 as leaders prepare for this year’s COP29 conference
• Distributed energy solutions company Correlate Energy Corp. is focused on helping companies more fully transition to renewable energy through localized clean energy solutions and microgrids, primarily through superior green technologies and the structuring of uniquely affordable financing
• The company has completed a number of notable energy transition projects across the country, and collectively its leadership team has developed, financed and deployed more than $2 billion in clean energy projects

As this year’s United Nations Climate Change Conference (COP29) approaches, the challenges surrounding renewable energy adoption and financing for the necessary changes are being newly highlighted by governmental leaders around the globe as they prepare to discuss potential increases to their nationally determined contributions (“NDCs”).

During a recent Petersberg Climate Dialogue gathering, the president of last year’s COP28 conference emphasized four main priorities for climate finance: bolstering infrastructure, advancing technology, investing in human capital, and focusing on the Global South, according to a SolarQuarter report (https://ibn.fm/EzTna). A $12 trillion investment by the nations is needed to triple global renewable energy capacity by 2030, he said.

Distributed energy solutions company Correlate Energy (OTCQB: CIPI) is a unique source for helping make renewable energy accessible to companies seeking to transition from more carbon-intensive fuels as part of this worldwide effort to forestall the harms of pollution-driven changes to the environment. The company’s focus on solar energy infrastructure, for example, is a result of solar’s ability to “beat the grid for costs,” President and CEO Todd Michaels said during an interview earlier this year (https://ibn.fm/6FUyJ).

Some of Correlate’s more notable solar energy projects throughout the country include an 8.2 MW rooftop solar energy project for Las Vegas’ MGM Mandalay Resort, a 12.9 MW system for Arizona State University responsible for 71 percent of campus solar output, a 6.48 MW project for NFL stadiums in California, New York, Washington and Massachusetts, and a 4.5 MW system for Albertsons-Safeway stores in California.

Correlate’s leadership team has collectively developed, financed, and deployed more than $2 billion in clean energy projects, and through the establishment of decentralized systems they are now building and selling localized clean energy solutions and microgrids for industrial, commercial, and residential customers.

The company is also growing dependable income by retaining ownership of some energy systems and the ongoing revenue benefit they would provide. Through M&A activity, Correlate also expects to strategically develop its portfolio for even greater efficiencies and profitability.

Correlate’s efforts are helping the U.S. achieve key priorities for climate finance identified by the COP28 president in Petersberg. “We are creating a powerful synergy that empowers businesses to navigate the transition to a low-carbon future with confidence,” Michaels stated (https://ibn.fm/8VV42).

For more information, visit the company’s website at www.Correlate.Energy, including the following:

Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.Correlate.Energy/our-process
Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.Correlate.Energy/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Bebuzee is preparing for the official launch of its Super App, which is poised to be the first Super App in America and Europe
• The official launch follows a beta testing phase that began last July
• The company believes the Super App will revolutionize the digital world by offering an all-in-one, seamless platform designed to integrate a continuously expanding roster of services
• The Super App brings together content streaming, social media, messaging, e-commerce, real estate exploration tools, a digital asset trading platform, productivity tools, and so much more

Last summer, Bebuzee (OTC: BBUZ), a company looking to redefine how people connect, engage, and thrive in the digital era, launched in beta its flagship product, a Super App that offers users a centralized hub for all their communication and entertainment needs. In the press release announcing the beta launch (https://ibn.fm/o5kfc), the company termed the Super App a “symbol of our commitment to innovation and excellence,” further noting that the groundbreaking technologies packaged into its Super App would “revolutionize the industry and set a new standard for digital platforms.”

The launch was an extension of efforts to solve a gap in the market: Bebuzee had observed consumers’ frustrations of constantly needing to switch between applications when hunting for information. To the company, this represented an opportunity to provide various apps and functionalities on an all-in-one platform. And the company is closing in on making this a reality with the beta phase now drawing to an imminent end.

Recently, Bebuzee announced that it is preparing for the official launch of the Super App. The Super App is set to offer an all-in-one, seamless platform that integrates multiple services, thus revolutionizing the digital world. The platform is poised to be the first Super App in America and Europe and represents a new dawn for digital integration, according to the company (https://ibn.fm/DvRAa).

The Bebuzee Super App integrates content streaming, social media, messaging, e-commerce, real estate exploration tools, a digital asset trading platform, productivity tools, and more. What’s more, according to the company, the Super App, is differentiated as the only “social media platform to localize its content for specific countries and also the only streaming service to offer movies, documentaries, series talk shows, and more at no cost to the viewer.” As a result of these unique capabilities and offerings, the company says, the Bebuzee Super App has essentially “no competition.”

To put its differentiated capabilities into perspective, the Super App’s core features include video streaming; messaging; photo sharing; Shortbuz, a tool that enables users to make short-form entertaining videos; Properbuz, a global real estate search tool; TravelBuz, an online travel agency for lodging reservations and other travel products; EventBuz, a ticket exchange and resale service; FlightBuz, a flights-search engine and travel agency; Bebuzee Pay, a mobile payment and digital wallet service; location reviews; Blogbuz, a service that scans the world’s news, features, and information flow and displays it to readers, offering them the best of the internet in one place; and ShoppingBuz, an e-commerce service (https://ibn.fm/iq04r).

By merging these cutting-edge capabilities and features into an all-in-one solution, the Super App provides users with a seamless, simplified, enriched, and immersive digital experience that is further complemented by a user-friendly interface. The company believes that these and other features and capabilities will ultimately make the Super App indispensable to users’ daily lives.

“The Bebuzee Super App is not just an app; it’s a revolution. We’re about to change the game by offering a comprehensive digital ecosystem that caters to every user’s needs, all within a single platform. This is more than an app; it’s a new way of life for social media users globally. We can’t wait for everyone to experience the future of digital engagement,” said Joe Onyero, CEO of Bebuzee, in the press release announcing plans for the official launch.

The official launch of the Super App is set to position Bebuzee at the forefront of a growing super apps market, which is expected to reach $722.4 billion by 2023 from $58.6 billion in 2022, growing at a 28.9% CAGR, according to analysts at Allied Market Research (https://ibn.fm/bU0Oa). And with a 2022 survey showing that Australia, Germany, the United Kingdom, and the United States are among the leading global markets for super apps (https://ibn.fm/euBuj), Bebuzee has taken a strategic approach with its initial plans to introduce its Super App in Europe and America.

For more information, visit the company’s website at www.Bebuzee.com.

NOTE TO INVESTORS: The latest news and updates relating to BBUZ are available in the company’s newsroom at https://ibn.fm/BBUZ

• Lexaria has entered an agreement wherein an existing accredited investor has exercised all their warrants to purchase shares
• The company has received $4.7 million from this undertaking, prior to deducting estimated offering expenses
• Proceeds fully fund Lexaria’s entire planned 2024 GLP-1 R&D program, leaving additional excess capital for general purposes

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its entry into a warrant exercise agreement with an existing accredited investor to exercise in full certain existing warrants initially issued in October 2023 and February 2024. The warrants will be exercised at $0.97 and $2.185 per share, respectively, with the whole undertaking yielding approximately $4.7 million, prior to deducting estimated offering expenses (https://ibn.fm/DJkII).

Proceeds from this offering will fund the 2024 GLP-1 research program and go into Lexaria’s working capital. Chris Bunka, the company’s CEO, noted that the funds will further extend its operational runway deep into 2025, an integral milestone given its project pipeline, specifically its focus on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year.

“These additional cash proceeds of $4.7 million further extend Lexaria’s operational runway deep into 2025 and allow us to execute our 2024 plans at an aggressive pace,” noted Mr. Bunka.

This announcement closely follows Lexaria’s recent milestone of three additional patents to its portfolio. In April 2024, the company received two newly granted patents in the U.S. and one in Japan. The first two patents fell under the company’s patent family #24: Compositions and Methods for Treating Epilepsy, while the third fell under patent family #18: Compositions and Methods for Enhanced Delivery of Antiviral Agents. While the company maintains its standing on the value of its intellectual property and continues to pursue that, its focus for 2024 has been specifically focused on GLP-1 studies.

“Our R&D plans for 2024 are very tightly focused and will be concentrated mainly on GLP-1 investigations. We are not at this time planning additional 2024 research in antiviral nicotine, or PDE5 sectors. We have solid early-stage data in each of those areas that will allow us to build upon those at the right time,” noted Mr. Bunka (https://ibn.fm/C3Vqx).

The $4.7 million will be integral in realizing this objective for the company, even as it pushes for patent applications. With this, its management maintains that its hard work will prove itself in 2024, ultimately creating additional shareholder value.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• SenesTech, a rodent fertility control product provider, is projecting an increase in demand for its Evolve(TM) Soft Bait
• This follows the rising cases of human leptospirosis in New York, an infection associated with exposure to rat urine
• Evolve offers a humane approach to controlling the rodent population, with the potential for complete elimination in 12 to 18 months
• Evolve contributes a significant chunk of SenesTech’s revenue, and the company projects that this will continue to be the case given recent developments

SenesTech (NASDAQ: SNES), a rodent fertility control product provider, and inventor of the only EPA-registered contraceptive for male and female rats, is expecting an increase in the demand for its product offering in the wake of the rising cases of human leptospirosis, particularly in New York. As an infection associated with exposure to rat urine, the rising cases have highlighted New York’s worsening rat problem and further prompted the need for more sustainable and practical solutions (https://ibn.fm/HSkgl).

Human leptospirosis has been linked to residential or occupational exposure to rat urine in environments such as soil and water, as well as materials contaminated with rat urine, such as trash bags or bins containing food waste. Symptoms of the condition include coughing, diarrhea, vomiting, jaundice, rash, and conjunctival suffusion. If left untreated, it can lead to kidney failure, liver damage, respiratory distress, and even meningitis.

Previously, the city employed various methods of controlling rat populations, including rodenticides, and even a “rat czar” was tasked with dealing with the issue. Given the inefficiency of these approaches, earlier in the year, a new bill was proposed by an Upper West Side City Council Member, seeking to ban the use of rodenticide in the city’s war on rats. The move sought to explore more humane methods with guaranteed results in the long term.

“This is not a problem we can kill our way out of. It’s time to embrace these more common sense and humane methods,” noted Jakob Shaw, a special project manager for People for the Ethical Treatment of Animals (https://ibn.fm/PmYT4).

In its earlier venture into exploring rodent contraceptives, New York City had used SenesTech’s ContraPest(R) as an alternative to rodenticide. Given its liquid form, it proved challenging to use despite posting a rat reduction of up to 68% in controlled studies. In subsequent long term field studies, ContraPest showed reductions in rats up to 90%. SenesTech, however, now has its new soft bait product, Evolve(TM), launched in January 2024, and proving extremely popular due to its ease of use and effectiveness. Studies have shown that the product could help reduce rat populations by 50% in just six months.

“If you’ve gotten the whole population on birth control, you should see close to a complete elimination of that population in 12 to 18 months,” noted Dan Palasky, SenesTech’s Chief Technical Officer (“CTO”). “You’re not controlling the death rate. You’re controlling the birth rate,” he added (https://ibn.fm/1OjPY).

With the cases of leptospirosis hitting 24 in 2023, higher than in any prior year, it is essential now, more than ever, to address the rat menace in the city. Given this mounting pressure, SenesTech anticipates a growth in demand for its Evolve soft bait. Since its launch, SenesTech has seen an uptick in demand, and Evolve is already contributing a significant portion of the company’s revenue. The company expects this trajectory to continue, even as it works to introduce a soft bait contraceptive product for mice.

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

• Cannabis retail dispensaries in Arizona have grown to upwards of 168 locations as of January 2024
• Nonetheless, only 1% of Arizona’s commercial properties are eligible for use by the cannabis industry
• Zoned Properties has been a key partner for the industry in helping cannabis companies establish a physical retail presence
• The company has recently announced the approval of a $1 million share buyback plan

The legalized sale of recreational cannabis in Arizona has grown from strength to strength. Possession and cultivation of cannabis across the state became legal on November 30, 2020, with the state-licensed sale of recreational cannabis commencing on January 22, 2021 making Arizona the quickest state in U.S. history to begin retail sales post recreational legalization. Cannabis sales in the state drove over $1.4 billion in revenues in 2023, with the number of dispensaries swelling to 292 as of January 2024 (https://ibn.fm/ky6yg). Nevertheless, further expansion for the industry is easier said than done; at present, only 1 percent of Arizona’s commercial real estate properties are applicable to cannabis operators, imposing a further constraint on the growth and development of the state’s cannabis retail market.

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company focused on acquiring value-add real estate within the regulated cannabis industry in the United States, has been amongst the early leaders in facilitating the transition of the cannabis industry towards the physical retail space. The company maintains a portfolio of six investment properties located across Arizona, Michigan and Illinois; with each of its leased properties occupied by commercial cannabis-linked businesses, the company currently enjoys a 100% occupancy rate with a weighted average lease term of over 10 years.

Zoned Properties has been amongst the leaders in identifying and procuring registered cannabis facilities, which can subsequently be sub-leased to the cannabis industry. Bryan McLaren, Chairman and CEO of Zoned Properties elaborated on the company’s methodology during a recent interview with the Bell2Bell podcast (https://ibn.fm/CtsVE).

“Our company and our team go into these state marketplaces and we identify, qualify and get these properties approved that can be utilized as regulated cannabis facilities. In the best-case scenario, what we’re doing is securing a piece of retail real estate – an old bank, an old restaurant, an old quick service retail location – getting that property approved to be used as a cannabis site called a retail dispensary and leasing that property out to a third-party tenant with a cannabis license in that location under a long-term lease agreement.”

Zoned Properties’ unique business model has translated into a faster rate of operational growth, with the company recently revealing that it had acquired a further two sites for use as potential dispensary locations. Separately, the company has looked to combine its ambitious focus on growth with a desire to maximise total shareholder returns; Zoned Properties recently announced that its Board of Directors has approved a stock repurchase program, pursuant to which the company was authorized to purchase up to $1 million of its common stock over an unlimited time period (https://ibn.fm/IehV5).

“As our business continues to outperform in a challenging overall operating environment, we are thrilled to announce this share repurchase program. The approval of this program demonstrates the management teams and board’s confidence in our prospects for the future, ongoing operational strength, and sound capital structure,” stated McLaren. “As we scale the investment portfolio, we are keeping conservative in our capital allocation strategy while also acknowledging the significant valuation gap between our public valuation and tangible book value. Due to this, it is crucial for us to be adaptable and make sure we are doing everything possible to increase shareholder value. As always, we remain committed in our strategic focus, and look forward to updating shareholders on our progress,” he continued.

For more information, visit the company’s website at www.ZonedProperties.com.

NOTE TO INVESTORS: The latest news and updates relating to ZDPY are available in the company’s newsroom at https://ibn.fm/ZDPY

• SOBRsafe, providing the latest in transdermal alcohol detection solutions, has signed another new customer, one that provides full continuum care, from inpatient detox and residential treatment to outpatient services, and has now installed SOBRcheck(TM) in each of its four facilities to enable point-of-care screening
• The customer is also evaluating SOBRsafe’s wearable band, SOBRsure(TM), for continuous monitoring in an outpatient application
• The new Florida client is one of sixteen new accounts that SOBRsafe secured during the first quarter of 2024
• The global alcohol sensor market was valued at $2.3 billion in 2022 and is expected to grow at a CAGR of 13.7%, resulting in a value of $6.3 billion by 2030

SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol detection solutions, recently announced that they have signed a hardware/software agreement with a four-facility behavioral health provider based in Florida. (https://ibn.fm/7cxba).

The customer provides the full continuum of care, from inpatient detox and residential treatment to outpatient services, and has now installed SOBRcheck(TM) in each of its four facilities to enable point-of-care screening. The customer is also evaluating SOBRsafe’s wearable band, SOBRsure(TM), for continuous monitoring in an outpatient application.

The new client is one of sixteen new accounts that SOBRsafe secured during the first quarter of 2024. These new accounts represent a jump in growth for the company, driven by products that offer non-invasive, efficient, hygienic and connected alcohol detection solutions that legacy alcohol detection technologies can’t match.

The global alcohol sensor market was valued at $2.3 billion in 2022 and is expected to grow at a CAGR of 13.7%, resulting in a value of $6.3 billion by 2030 (https://ibn.fm/jRJbc). Factors fueling market growth include rising alcohol consumption rates, stricter laws pertaining to alcohol consumption, and more effective technologies that facilitate detection and enforcement.

SOBRsafe currently offers the following products to help with alcohol detection in the behavioral health and justice sectors:

• SOBRsafe(TM): Committed to its mission of preserving lives, enhancing productivity, generating significant economic advantages, and fostering positive behavioral change, SOBRsafe has developed the patent-pending SOBRsafe platform. This platform enables non-invasive alcohol detection, real-time reporting, and historical data aggregation on a scalable level. SOBRsafe offers a versatile solution applicable across various sectors including behavioral health, fleet and facility safety, youth drivers, and judicial markets.
• SOBRcheck(TM): SOBRcheck represents the company’s stationary identification and alcohol monitoring solution, delivering swift, targeted alcohol tests at specific points in time. In a hygienic and real-time manner, SOBRcheck authenticates user identity while determining alcohol presence or absence. SOBRcheck delivers immediate results securely to administrators, aiding in the effective management of existing substance abuse policies.
• SOBRsure(TM): SOBRsure introduces the company’s transdermal wearable for alcohol detection. Providing continuous mobile alcohol monitoring, SOBRsure discreetly identifies alcohol presence in the body in real-time. SOBRsure also offers app-based alcohol detection alerts, precise location tracking, and notifications for band removal.

SOBRsafe Director of Commercial Development Eddie Kilroy, said the new Florida customer historically used breathalyzers for select check-ins, but felt these legacy devices were too inefficient and invasive for uniform entry screening. “With SOBRcheck, the provider can verify the absence of alcohol in just 10 seconds or less, in a humane and cost-effective manner. The customer is streamlining operations with automatic results reporting, and electronic records searchable by individual and location,” Kilroy explained. “Switching to SOBRcheck has empowered them to enhance and expand their screening protocols, while likely reducing attempts to subvert the testing process.”

For more information, visit the company’s website at www.SOBRsafe.com. 

NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://ibn.fm/SOBR

• SUIC CEO Hank Wang recently joined Bell2Bell Podcast host Stuart Smith to discuss the company’s operations and business model, recent milestones, and plans for 2024
• The venture financing and support company, through its I.Hart Group and Boom Fintech subsidiaries, has entered into agreements that set the stage for significant expansion
• SUIC’s I.Hart Group recently signed a brand corporation agreement with 7-Eleven, expected to promote the company’s long-term growth
• The company’s Boom Fintech is working on financing that will support the creation of a revolutionary B2B financing platform and boost supply chain integration for suppliers
• SUIC expects to significantly expand its product markets, making 2024 its best year yet, according to Hank

SUIC Worldwide Holdings (OTC: SUIC), a provider of research and development, venture financing, and investment for public and private companies, was featured in a recent episode of The Bell2Bell Podcast. SUIC CEO Hank Wang joined host Stuart Smith to discuss the company’s operations and business model, recent milestones, and plans for 2024 (https://ibn.fm/dy633).

According to Mr. Hank, SUIC targets opportunities to enhance and streamline existing supply chain and financial processes. The company is the largest shareholder and major operating partner of Beneway Holdings Group, Ltd. USA (“Beneway USA”), which itself is the parent company of I.Hart Group Taiwan, a company that operates 150 global franchised locations under a variety of brands and products, and Boom Fintech, a fintech company that develops and offers an all-in-one platform designed for merchants.

Over the last few months, both I.Hart Group and Boom Fintech have made substantial strides that bring SUIC closer to its expansion goals. In February, I.Hart, whose portfolio of brands and products includes MONGA(C) Taiwan style fried chicken, flower tea drinks, cloud kitchen management, AI smart machines, dumplings, and more, signed a brand cooperation agreement with 7-Eleven Group, Taiwan’s largest convenience store chain with more than 6,800 stores countrywide. The agreement opens up MONGA(C) Fried Chicken’s multi-channel distribution in Taiwan and through 7-Eleven’s international network of stores (https://ibn.fm/1MLUH).

This agreement, SUIC believed, also opens doors for more cooperation with U.S. brands and promotes overall business expansion, a belief that Hank reaffirmed during the recent interview. Hank noted that the cooperation with 7-Eleven represents “an unprecedented prospect to promote our long-term growth,” further noting that the company will leverage its fast-growing competitive affiliations to “offer additional value to customers in different parts of the world.” In addition, and separately, I.Hart is working on integrating more successful brands into its family, targeting 25 different brands to enter the US franchise market in 50 states. And as Hank put it in the interview, the company hopes to replicate I.Hart Group’s unique multi-brand model in the U.S.

On its part, Boom Fintech, which holds nine revolutionary fintech patents, recently reported to work with BD Bankers to access credit of up to $100 million in intellectual property (“IP”) financing intended to support the creation of a revolutionary B2B financing platform for merchants and franchisees and boost supply chain integration for suppliers (https://ibn.fm/JfHzb).

The efforts of both I.Hart Group and Boom Fintech are expected to accelerate Beneway’s plans for an initial public offering (“IPO”). Beneway intends to file the S-1 form with the Securities and Exchange Commission (“SEC”) later this year as part of its plans to list on a national stock exchange in what is expected to maximize SUIC’s corporate and shareholder value, according to Hank. In addition to the planned IPO, SUIC has additional plans for 2024.

“SUIC expects to significantly expand our product markets, making 2024 its best year yet,” explained Hank. “Looking forward, SUIC will continue to introduce more co-branding products in the U.S. with other prestigious brands to expand our business. [In addition,] we would like to focus on Fintech through industry supply chain integration, global chain and franchise expansion, and other supply chain integrations to enhance and streamline existing processes and establish new and exciting business models that will create revolutionary products and services.”

To listen to the interview, please visit https://ibn.fm/vViFQ

For more information, visit the company’s website at www.SinoUnitedCo.com.

NOTE TO INVESTORS: The latest news and updates relating to SUIC are available in the company’s newsroom at https://ibn.fm/SUIC

Executives and professionals of the biopharma and medical device realm are invited to attend the 8th Decentralized & Hybrid Clinical Trial conference organized by DGE, May 15-16, 2024, in Philadelphia, PA. The event focuses on optimizing the technical processes, regulatory compliance, and design adaptability of remote clinical trials.

The conference is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing b2b events. The global event company caters to the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries.

During COVID-19, remote and decentralized clinical trials (DCTs) came into practice. Since then, the application of decentralized methods for clinical trials has grown phenomenally. Thus, clinical trial teams have to be prepared and equipped to incorporate the relevant technologies for decentralized methods. This conference explores insights into challenges and offers solutions for selecting the right technologies for patients and sites, understanding FDA guidelines, overcoming logistical hurdles, and much more.

Experts conducting speaker sessions will also talk about how the power of AI can be harnessed for various clinical trial processes such as attaining patient data in DCTs, and also when solving issues of tech affordability, bias, and inconsistent data management. Additional topics include the importance of home sampling for decentralized trials, and uses of eConsent.

The event is meticulously curated to address challenges and offer solutions to the clinical trial industry. DGE offers a phenomenal networking platform to meet, learn, and connect with the right professionals and influencers. Connect with industry leaders, showcase unique ideas and presentations, and get the latest updates to stay ahead of the competition.

To know more, please visit https://ibn.fm/r97GX.